Samrat Pharmachem has informed that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 to consider and approve the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended September 30, 2019.
The above information is a part of company’s filings submitted to BSE.